Biggest News Aggregation in the World
📰 Markm Davis News

Page 2 - Markm Davis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Markm Davis. Real-time updates on events, politics, business and more.

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases - read this article along with other careers information, tips and advice on BioSpace
Al Iskandariyah Michael Rosenblum Julie Rathbun Steven Gillis Lucio Iannone Markm Davis

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

2021 Szent-Györgyi Prize Awarded to Pioneering Research Duo Who Have Paved the Path to Life-Saving T-Cell Receptor-Based Cancer Immunotherapies

Share this article Share this article ROCKVILLE, Md., Feb. 18, 2021 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that the 2021 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Tak W. Mak, Ph.D., senior scientist at the Princess Margaret Cancer Centre and university professor at the University of Toronto, and Mark M. Davis, Ph.D., professor of microbiology and immunology at the Stanford University School of Medicine, for their break...
University Of Washington United States Dana Farber Cancer Institute Websterk Cavenee Bradley Gillenwater Carlom Croce

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication January 26, 2021 08:30 ET | Source: Vaxart, Inc. Vaxart, Inc. South San Francisco, California, UNITED STATES New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxartïżœ...
Peters Kim Markm Davis Sean Tucker Andrei Floroiu Stanford Institute For Immunology Merck Research Laboratories

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

Published: Jan 26, 2021 New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine Data from Vaxart’s Phase I COVID-19 trial expected to be released next week SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vaxart Inc., (NASDAQ: VXRT), a clinical-stage ...
Peters Kim Davidr Holmes Markm Davis Gloria Gasaatura Sean Tucker Andrei Floroiu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science